ABBV
AbbVie Inc.C5415-min delayed · EOD close261.72 +0.67% upas of 2026-09-02mkt cap $462B
Pharmaceutical Preparations · SIC 2834 · CIK 0001551152
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $64.4B | 2026-06-30 | 10-Q · 0001551152-26-000026 |
| Revenue (prior year) | $56.3B | 2024-12-31 | 10-K · 0001551152-25-000020 |
| Operating income | $16.9B | 2026-06-30 | 10-Q · 0001551152-26-000026 |
| Net income | $6.3B | 2026-06-30 | 10-Q · 0001551152-26-000026 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $135B | 2026-06-30 | 10-Q · 0001551152-26-000026 |
| Current assets | $33.7B | 2026-06-30 | 10-Q · 0001551152-26-000026 |
| Current liabilities | $41.6B | 2026-06-30 | 10-Q · 0001551152-26-000026 |